Analytical Advances in the Ex Vivo Challenge Efficacy Assay

The ex vivo challenge assay is being increasingly used as an efficacy endpoint during early human clinical trials of HIV prevention treatments. There is no standard methodology for the ex vivo challenge assay, although the use of different data collection methods and analytical parameters may impact...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:AIDS Res Hum Retroviruses
Main Authors: Richardson-Harman, Nicola, Parody, Robert, Anton, Peter, McGowan, Ian, Doncel, Gustavo, Thurman, Andrea Ries, Herrera, Carolina, Kordy, Kattayoun, Fox, Julie, Tanner, Karen, Swartz, Glenn, Dezzutti, Charlene S.
Format: Artigo
Jezik:Inglês
Izdano: Mary Ann Liebert, Inc. 2017
Teme:
Virology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5372762/
https://ncbi.nlm.nih.gov/pubmed/27841671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2016.0073
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki